A randomized controlled trial of oral phosphate binders in the treatment of pseudoxanthoma elasticum

Journal of the American Academy of Dermatology

Volumn 65, Issue 2, 2011, Pages 341-348

  Yoo, Jane Y ^a   Blum, Robin R ^a   Singer, Giselle K ^a   Stern, Dana K ^a   Emanuel, Patrick O ^a   Fuchs, Wayne ^a   Phelps, Robert G ^a   Terry, Sharon F ^b   Lebwohl, Mark G ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b PXE International   (United States)

Author keywords

oral phosphate binders; pseudoxanthoma elasticum; randomized controlled clinical trial; treatment

Indexed keywords

CALCIUM; MAGNESIUM STEARATE; PLACEBO; SEVELAMER;

ANGIOID STREAK; ARTICLE; BONE DENSITY; CALCIUM BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONSTIPATION; CONTROLLED STUDY; CORNEA NEOVASCULARIZATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUSEN; GASTRITIS; HUMAN; HUMAN TISSUE; IRRITABLE COLON; MENORRHAGIA AND METRORRHAGIA; NAUSEA; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSEUDOXANTHOMA ELASTICUM; PUNCH BIOPSY; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SKIN DISCOLORATION; SKIN EXAMINATION; STOMACH DISCOMFORT; TREATMENT INDICATION; VISUAL IMPAIRMENT;

ADMINISTRATION, ORAL; ADULT; ANALYSIS OF VARIANCE; BIOPSY, NEEDLE; CALCIUM; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; POLYAMINES; PROSPECTIVE STUDIES; PSEUDOXANTHOMA ELASTICUM; REFERENCE VALUES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 79959509616     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2010.05.023     Document Type: Article

References (23)

1. F. Ringpfeil, and J. Uitto Pseudoxanthoma elasticum J.L. Bolognia, J.L. Jorrizo, R.P. Rapini, Dermatology 2003 Mosby Philadelphia 1524 1526
2. K.H. Neldner Pseudoxanthoma elasticum Clin Dermatol 6 1988 1 159
3. D.W. Sherer, G. Singer, J. Uribarri, R.G. Phelps, A.N. Sapadin, and K.B. Freund Oral phosphate binders in the treatment of pseudoxanthoma elasticum J Am Acad Dermatol 53 2005 610 615 (Pubitemid 41399927)
4. J.G. Clarkson, and R.D. Altman Angioid streaks Surv Ophthalmol 26 1982 235 246 (Pubitemid 12117361)
5. Q. Jiang, M. Endo, F. Dibra, K. Wang, and J. Uitto Pseudoxanthoma elasticum is a metabolic disease J Invest Dermatol 129 2009 348 354
6. A.N. Sapadin, M.G. Lebwohl, S.A. Teich, R.G. Phelps, D. DiCostanzo, and S.R. Cohen Periumbilical pseudoxanthoma elasticum associated with chronic renal failure and angioid streaks-apparent regression with hemodialysis J Am Acad Dermatol 39 1998 338 344 (Pubitemid 28367311)
7. R.P. Finger, P.C. Issa, M.S. Ladewig, C. Götting, C. Szliska, H.P. Scholl, and F.G. Holz Pseudoxanthoma elasticum: genetics, clinical manifestations and therapeutic approaches Surv Ophthalmol 54 2009 272 285
8. F. Ringpfeil, M.G. Lebwohl, A.M. Christiano, and J. Uitto Pseudoxanthoma elasticum: mutations in the MRP6 gene encoding a transmembrane ATP-binding cassette (ABC) transporter Proc Natl Acad Sci U S A 25 2000 223 227
9. O. Le Saux, Z. Urban, C. Tschuch, K. Csiszar, B. Bacchelli, and D. Quaglino Mutations in a gene encoding an ABC transporter cause pseudoxanthoma elasticum Nat Genet 25 2000 223 227 (Pubitemid 30394998)
10. A.A. Bergen, A.S. Plomp, E.J. Schuurman, S. Terry, M. Breuning, and H. Dauwerse Mutations in the ABCC6 cause pseudoxanthoma elasticum Nat Genet 25 2000 228 231 (Pubitemid 30394999)
11. B. Struk, L. Cai, S. Zach, W. Ji, J. Chung, and A. Lumsden Mutations of the gene encoding the transmembrane protein ABC-C6 cause pseudoxanthoma elasticum J Mol Med 78 2000 282 286 (Pubitemid 30489712)
12. J. Uitto, and Q. Jiang Pseudoxanthoma elasticum-like phenotypes: more diseases than one J Invest Dermatol 127 2007 507 510
13. J. Uitto, L. Pulkkinen, and F. Ringpfeil Molecular genetics of pseudoxanthoma elasticum: a metabolic disorder at the environment-genome interface? Trends Mol Med 7 2001 13 17 (Pubitemid 33718077)
14. Q. Jiang, Q. Li, and J. Uitto Aberrant mineralization of connective tissues in a mouse model of pseudoxanthoma elasticum: systemic and local regulatory factors J Invest Dermatol 127 2007 1392 1402 (Pubitemid 46762987)
15. D. Quaglino, F. Boraldi, D. Barbiri, A. Croce, R. Tiozzo, and I. Pasquali-Ronchetti Abnormal phenotype of in vitro dermal fibroblasts from patients with pseudoxanthoma elasticum (PXE) Biochem Biophys Acta 1501 2000 51 62 (Pubitemid 30155894)
16. D. Quaglino, L. Sartor, S. Garbisa, F. Boraldi, A. Croce, and A. Passi Dermal fibroblasts from pseudoxanthoma elasticum patients have raised MMP-2 degradative potential Biochem Biophys Acta 1741 2005 42 47 (Pubitemid 40824988)
17. P. Bhatnagar, K.B. Freund, R.F. Spaide, J.M. Klancnik Jr, M.J. Cooney, and I. Ho Intravitreal bevacizumab for the management of choroidal neovascularization in pseudoxanthoma elasticum Retina 27 2007 897 902 (Pubitemid 47479384)
18. R.P. Finger, P. Charbel Issa, M. Ladewig, F.G. Holz, and H.P. Scholl Intravitreal bevacizumab for choroidal neovascularization associated with pseudoxanthoma elasticum Br J Ophthalmol 92 2008 483 487 (Pubitemid 351497973)
19. R. Pedersen, W. Solimen, H. Lund-Andersen, and M. Larsen Treatment of choroidal neovascularization using intravitreal bevacizumab Acta Ophthalmol Scand 85 2007 526 533 (Pubitemid 47163114)
20. A. Teixeira, N. Moraes, M.E. Farah, and P.P. Bonomo Choroidal neovascularization treated with intravitreal injection of bevacizumab (Avastin) in angioid streaks Acta Ophthalmol Scand 84 2006 835 836 (Pubitemid 44688345)
21. E. Ritz The clinical management of hyperphosphatemia J Nephrol 18 2005 221 228 (Pubitemid 41078939)
22. -/- mice: effects of dietary modifications and a phosphate binder-a preliminary study Exp Dermatol 17 2007 203 207 (Pubitemid 351233865)
23. -/-)) J Invest Dermatol 129 2009 1388 1394